Concept DHA
- Product NDC
- 52747-621
- Requested package NDC
- 52747-621-30
- 11-digit product format
- 527470621
- Labeler code
- 52747
- Product ID
- 52747-621_aaee698d-9522-49c9-afd3-d0c5d52e3ccd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Vitamin- Mineral Omega-3 Supplement
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- U.S. Pharmaceutical Corporation
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2009-06-24
- Substance
- FERROUS FUMARATE; IRON; ASCORBIC ACID; FOLIC ACID; THIAMINE MONONITRATE; RIBOFLAVIN; NIACIN; CALCIUM PANTOTHENATE; PYRIDOXINE HYDROCHLORIDE; BIOTIN; CYANOCOBALAMIN; CUPRIC SULFATE; MAGNESIUM SULFATE, UNSPECIFIED FORM; ZINC SULFATE, UNSPECIFIED FORM; OMEGA-3-ACID ETHYL ESTERS
- Active strength
- 17.5; 17.5; 25; 1; 2; 3; 1.8; 5; 25; 300; 12.5; 2; 5; 10; 200 mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1
- Pharmacologic classes
- Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Fatty Acids, Omega-3 [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Omega-3 Fatty Acid [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2022-04-09 23:13 UTC · source 2022-04-08 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | 110d247fa046… | a55b01930146… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Concept DHA
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FERROUS FUMARATE | 17.5 mg/1 |
| IRON | 17.5 mg/1 |
| ASCORBIC ACID | 25 mg/1 |
| FOLIC ACID | 1 mg/1 |
| THIAMINE MONONITRATE | 2 mg/1 |
| RIBOFLAVIN | 3 mg/1 |
| NIACIN | 1.8 mg/1 |
| CALCIUM PANTOTHENATE | 5 mg/1 |
| PYRIDOXINE HYDROCHLORIDE | 25 mg/1 |
| BIOTIN | 300 ug/1 |
| CYANOCOBALAMIN | 12.5 ug/1 |
| CUPRIC SULFATE | 2 mg/1 |
| MAGNESIUM SULFATE, UNSPECIFIED FORM | 5 mg/1 |
| ZINC SULFATE, UNSPECIFIED FORM | 10 mg/1 |
| OMEGA-3-ACID ETHYL ESTERS | 200 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R5L488RY0Q | Internal UNII lookup |
| E1UOL152H7 | Internal UNII lookup |
| PQ6CK8PD0R | Internal UNII lookup |
| 935E97BOY8 | Internal UNII lookup |
| 8K0I04919X | Internal UNII lookup |
| TLM2976OFR | Internal UNII lookup |
| 2679MF687A | Internal UNII lookup |
| 568ET80C3D | Internal UNII lookup |
| 68Y4CF58BV | Internal UNII lookup |
| 6SO6U10H04 | Internal UNII lookup |
| P6YC3EG204 | Internal UNII lookup |
| LRX7AJ16DT | Internal UNII lookup |
| DE08037SAB | Internal UNII lookup |
| 89DS0H96TB | Internal UNII lookup |
| D87YGH4Z0Q | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| bd2051f7-b887-46f6-8d4a-b099fcd08629 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52747-621-30 | 2022-08-12 | C162847 | 48780-1 | 956f9ecf-ca50-621f-e053-dbdaa90a74ad | see all prescribing information for Concept DHA |
| 52747-621-30 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-ca50-621f-e053-dbdaa90a74ad | see all prescribing information for Concept DHA |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52747-621-30 | Concept DHA | 30 in 1 BOTTLE, PLASTIC | CAPSULE, LIQUID FILLED | 30 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52747-621-30 | EA - Each | 52747-621 | a585753a-aaa7-4510-8c41-1ef37f0b1e99 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Concept DHA | VITAMIN- MINERAL OMEGA-3 SUPPLEMENT | U.S. Pharmaceutical Corporation | bd2051f7-b887-46f6-8d4a-b099fcd08629 | 2022-11-08 | Warnings | 52747-621-30 52747-621 52747062130 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 52747-621-30 | 52747062130 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (52747-621-30) | 2009-06-24 | 0000-00-00 | No | No | Current |